NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg HCPCS · Treatment
Classification Treatment Injections and Infusions (nononcologic) Injection - Immune Globulin (CMS RBCS)
First observed 2023
National scale 214,290 services ▲ 474.7% YoY · 378 beneficiaries (CY2024, Medicare FFS)
Medicare paid $11.3M · $52.74 avg / service, national
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups

8

Named groups billing this code
Named-group FFS services

117,380

Attributable volume · fee-for-service
FFS of Medicare

49%

Payer-mix frame
Services · year over year
Services YoY

+474.7%

FFS enrollment -2.2%
Volume, not care. A shrinking fee-for-service denominator is not a shrinking market.
Estimated all-Medicare volume estimate
FFS + estimated MA

~209,856 services

117,380 observed fee-for-service (56%) · ~92,476 estimated Medicare Advantage.

Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Top states — J1576 (CY2024)

Disclosed Medicare fee-for-service services by billing state; open a bar for that state's ranked market.

Billed → allowed → paid
Named-group submitted charges
$28.9M
Named-group allowed amount
$7.8M
Named-group Medicare payments
$6.2M
Avg charge / svc
$246
Avg allowed / svc
$66
Avg payment / svc
$53
Totals are named-group (attributable) sums. Allowed is Medicare’s fee-schedule recognized price — what CMS recognizes, before the 80% Medicare pays.
Average charge per group
$132 8 groups · avg submitted charge / service $254
Market analyticsPlatform Methods →

Search a single state to see that market's full analytics — the free tier previews every panel, gated.

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →
Unlock the Platform — the full read, every number below, code baskets, and export. Looking is free; the depth is paid. Notify me at launch →
Refine: group size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by J1576 services, highest first, CY2024
# Physician group activate to sort City activate to sort St activate to sort Specialty activate to sort Providers activate to sort J1576 svcs sorted descending — activate to reverse Submitted charges activate to sort Avg charge activate to sort Medicare $ locked column Share* activate to sort Phone
1 TRI-STATE NEUROLOGY PLLC MEMPHIS TN NEUROLOGY 4 54,350 $13,804,900 $254 premium 60.5% (901) 820-0141
2 DANIEL HEXTER MD PA ANNAPOLIS MD NEUROLOGY 7 32,210 $8,181,340 $254 premium 71.9% (410) 266-9694
3 SANGJIN OH MD PA GLEN BURNIE MD NEUROLOGY 2 12,590 $3,197,860 $254 premium 28.1% (410) 761-3900
4 SEMMES-MURPHEY CLINIC PC MEMPHIS TN NEUROSURGERY 65 6,620 $1,681,480 $254 premium 7.4% (901) 522-7700
5 ONCOLOGY SAN ANTONIO SAN ANTONIO TX HEMATOLOGY/ONCOLOGY 5 3,500 $465,960 $133 premium 100.0% (210) 490-2707
6 MISSISSIPPI ASTHMA AND ALLERGY CLINIC PA JACKSON MS ALLERGY/IMMUNOLOGY 15 3,440 $873,760 $254 premium 100.0% (601) 354-4836
7 HEM ONC ASSOCIATES OF THE TREASURE COAST, PA PORT SAINT LUCIE FL HEMATOLOGY/ONCOLOGY 6 3,010 $397,320 $132 premium 49.7% (772) 335-5666
8 CANCER PARTNERS OF NEBRASKA PC LINCOLN NE MEDICAL ONCOLOGY 30 1,660 $297,700 $179 premium 10.8% (402) 420-6090

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →